Role of proangiogenic Tie2+ monocytes (TEMs) in diabetes-associated macrovascular disease.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24416

Enrollment

Registered

2018-10-01

Start date

2018-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Macrovascular disease

Not applicable.

Inclusion criteria: Men and women Age above 17 years

Exclusion criteria: Type 1 diabetes Age below 18 years Incompetent

Measure	Time frame
- Amount of tie2+ Monocytes (TEMs) and its relation with macrovascular disease - Role of type 2 diabetes on TEMs expression	—

None listed

Source: NL-OMON (via WHO ICTRP)